Camden Louis Hebson, MD

1. "Frontiers in Fontan failure: A summary of conference proceedings.” Hebson C, Book W, Elder RW, Ford R, Jokhadar M, Kanter K, Kogon B, Kovacs AH, Levit RD, Lloyd M, Maher K, Reshamwala P, Rodriguez F, Romero R, Tejada T, Marie Valente A, Veldtman G, McConnell M. Congenit Heart Dis. 2017 Jan;12(1):6-16. doi: 10.1111/chd.12407. Epub 2016 Sep 6. 2. Risk Assessment and Management of the Mother with Cardiovascular Disease. Hebson C, Saraf A, Book WM. Clin Perinatol. 2016 Mar;43(1):1-22. doi: 10.1016/j.clp.2015.11.001. Review. 3. Elevated tricuspid regurgitant velocity as a marker for pulmonary hypertension in children with sickle cell disease: less prevalent and predictive than previously thought? Hebson C, New T, Record E, Oster M, Ejrlich A, Border W, James-Herry A, Kanaan U. J Pediatr Hematol Oncol. 2015 Mar,37(2):134-9. doi.1097/MPH.0000000000000184. 4. Hemodynamic phenotype of the failing Fontan in an adult population. Hebson CL, McCabe NM, Elder RW, Mahle WT, McConnell M, Kogon BE, Veledar E, Jokhadar M, Vincent RN, Sahu A, Book WM. Am J Cardiol. 2013 Dec 15;112(12):1943-7. dol: 10.1016/j.amjcard.2013.08.023. Epub 2013 Sept 25. 5. Electrocardiographic screening in children with attention-deficit hyperactivity disorder. Mahle WT, Henson C, Strieper MJ. Am J Cardiol. 2009 Nov 1;104(9):1296-9. dol: 10.1016/j.amjcard.2009.06.052